Our results suggested that plasma levels of IL-6 and IL-21 were significantly higher in active SLE patients than in HCs and inactive SLE patients, and plasma IL-21 levels were positively correlated with plasmablasts and activated ICOS+PD-1+cTfh cells in SLE patients. The gene discussed is IL6; the disease is systemic lupus erythematosus.